Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Fish and Richardson
Citi
Colorcon
Fuji
Harvard Business School
Express Scripts
Covington

Generated: July 15, 2018

DrugPatentWatch Database Preview

Bendroflumethiazide; nadolol - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for bendroflumethiazide; nadolol and what is the scope of bendroflumethiazide; nadolol freedom to operate?

Bendroflumethiazide; nadolol
is the generic ingredient in two branded drugs marketed by King Pharms Llc, Impax Labs, and Mylan, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for bendroflumethiazide; nadolol. Two suppliers are listed for this compound.
Summary for bendroflumethiazide; nadolol
Pharmacology for bendroflumethiazide; nadolol
Synonyms for bendroflumethiazide; nadolol
Bendroflumethiazide mixture with nadolol
C17H27NO4.C15H14F3N3O4S2
D153992480
LS-178520
Nadolol and bendroflumethazide
Nadolol and bendroflumethiazide
Nadolol/Bendroflumethiazide
SCHEMBL4066540

US Patents and Regulatory Information for bendroflumethiazide; nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 077833-002 Mar 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 078688-001 Feb 15, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 077833-001 Mar 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for bendroflumethiazide; nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Merck
Baxter
Daiichi Sankyo
Cerilliant
Healthtrust
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.